A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2
expression in human breast cancer cells
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 8, Pages 6408-6417
Publisher
Wiley
Online
2017-12-13
DOI
10.1002/jcb.26577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance
- (2017) Wei Meng et al. MEDICAL SCIENCE MONITOR
- Abstract 3316: The effects of dopamine receptor 2 on breast cancer tumor initiating cells
- (2016) Matthew Tegowski et al. CANCER RESEARCH
- An overview of triple-negative breast cancer
- (2015) Pankaj Kumar et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Dopamine Receptor Gene (DRD1-DRD5) Expression Changes as Stress Factors Associated with Breast Cancer
- (2015) Majid Pornour et al. Asian Pacific Journal of Cancer Prevention
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line
- (2015) Majid Pornour et al. Recent Patents on Anti-Cancer Drug Discovery
- Genome-Wide Meta-Analysis of Systolic Blood Pressure in Children with Sickle Cell Disease
- (2013) Pallav Bhatnagar et al. PLoS One
- Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
- (2012) Eleftherios Sachlos et al. CELL
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers
- (2012) Ada Piepoli et al. PLoS One
- Mechanisms and role of microRNA deregulation in cancer onset and progression
- (2011) Edenir Inês Palmero et al. GENETICS AND MOLECULAR BIOLOGY
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Role of microRNAs in endothelial inflammation and senescence
- (2011) Bing Qin et al. MOLECULAR BIOLOGY REPORTS
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Shielding the messenger (RNA): microRNA-based anticancer therapies
- (2011) Elena Sotillo et al. PHARMACOLOGY & THERAPEUTICS
- Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells
- (2011) D. Chakroborty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
- Micro-RNAs and breast cancer
- (2010) John Le Quesne et al. Molecular Oncology
- Catecholamines Regulate Tumor Angiogenesis
- (2009) D. Chakroborty et al. CANCER RESEARCH
- MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer
- (2009) Ming Shi et al. CANCER TREATMENT REVIEWS
- Post-transcriptional control of DGCR8 expression by the Microprocessor
- (2009) R. Triboulet et al. RNA
- MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer
- (2009) Enders K. O. Ng et al. Journal of Oncology
- MicroRNAs as biomarkers and therapeutic drugs in human cancer
- (2008) M. Osaki et al. BIOMARKERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now